Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT [Phase 2]

View source ↗

Summary

This phase 2 trial is evaluating the efficacy and safety of different light-dose regimens in port-wine stain treatment using Hemoporfin photodynamic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Port-wine Stain

Drugs mentioned

• Hemoporfin PDT (hematoporphyrin derivative (Hemoporfin) used in photodynamic therapy)

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: Port-wine Birthmarks, Port-Wine Stain | Phase 2 | Status: RECRUITING